Oxford Biomedica

Description

Oxford Biomedica provides end-to-end CDMO services for cell and gene therapy clients, using lentivirus, AAV, and other viral vectors to design, develop, manufacture, and deliver therapies from preclinical work to commercial launch.

Oxford Biomedica is located in the Oxford ecosystem.

Related

• TQ TherapeuticsTQ Therapeutics operates a CELLfinity platform that delivers in vivo cell and gene therapies using a proprietary EXiVO automated approach…
• CellabCellab CDMO provides development and GMP manufacturing services for advanced therapy medicinal products.
• CircioCircio develops circular RNA and immunotherapy medicines, including circVec AAV gene therapy work that uses circular RNA to enhance…
• SyngensysSyngensys develops synthetic gene promoters using transcriptional landscape analysis, computational design, selection, and validation to…
• NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…
• HALIXHALIX develops and GMP-manufactures biologics, including viral vectors and recombinant proteins, using mammalian expression systems,…
• NorthX BiologicsNorthX Biologics provides custom-fit biologics development and GMP manufacturing services, delivering process development, analytics,…
• VRG TherapeuticsVRG Therapeutics designs therapeutic miniproteins using a proprietary platform that combines AI-driven protein engineering with wet-lab…
• Hansa BiopharmaHansa Biopharma develops immunomodulating antibody-cleaving enzyme therapies that target and inactivate IgG antibodies, inhibiting…